Hospital effluent: Investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment

Science of the Total Environment

Volumn 430, Issue , 2012, Pages 109-118

  Verlicchi, P ^a   Al Aukidy, M ^a   Galletti, A ^a   Petrovic, M ^b,c   Barcelo D ^c,d  

^a UNIVERSITY OF FERRARA   (Italy)

^b CATALAN INSTITUTE FOR WATER RESEARCH ICRA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

Author keywords

Contribution; Hospital effluents; Mass loads; Pharmaceuticals; Risk analysis; Urban wastewater

Indexed keywords

CONTRIBUTION; ENVIRONMENTAL RISK ASSESSMENT; ENVIRONMENTAL RISKS; HOSPITAL EFFLUENT; LIPID REGULATORS; MASS LOAD; RECEPTOR ANTAGONISTS; TREATMENT PLANTS; URBAN EFFLUENTS; URBAN WASTEWATER;

ANTIBIOTICS; DRUG PRODUCTS; EFFLUENT TREATMENT; HOSPITALS; POLLUTION; RISK ANALYSIS; RISK ASSESSMENT;

EFFLUENTS;

AGENTS AFFECTING LIPID METABOLISM; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIURETIC AGENT; PSYCHOTROPIC AGENT; RECEPTOR BLOCKING AGENT;

CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; ENVIRONMENTAL RISK; HOSPITAL SECTOR; POLLUTANT SOURCE; RISK ASSESSMENT; URBAN AREA; WASTE FACILITY; WASTE TREATMENT; WASTEWATER; WATER TREATMENT;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EFFLUENT; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL MONITORING; HOSPITAL WASTE; ITALY; LIMIT OF DETECTION; POLLUTION MONITORING; POLLUTION TRANSPORT; PRIORITY JOURNAL; RISK ASSESSMENT; SEASONAL VARIATION; SUMMER; WASTE WATER TREATMENT PLANT; WINTER;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENVIRONMENTAL MONITORING; HOSPITALS; ITALY; LIMIT OF DETECTION; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; SEASONS; SEWAGE; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

ITALY;

EID: 84861332141     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.04.055     Document Type: Article

References (42)

1. Beier S., Cramer C., Koster S., Mauer C., Palmowski L., Schroder H.F., et al. Full scale membrane bioreactor treatment of hospital wastewater as forerunner for hot-spot wastewater treatment solutions in high density urban areas. Water Sci Technol 2011, 63:66-71.
2. Bell K.Y., Wells M.J.M., Traexler K.A., Pellegrin M.L., Morse A., Bandy J. Emerging pollutants. Water Environ Res 2011, 83:1906-1984.
3. Boillot C., Bazin C., Tissot-Guerraz F., Droguet J., Perraud M., Cetre J.C., et al. Daily physicochemical, microbiological and ecotoxicological fluctuations of a hospital effluent according to technical and care activities. Sci Total Environ 2008, 403:113-129.
4. Daughton C., Ternes T. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107:907-938.
5. De Souza S.M.L., De Vasconcelos E.C., Dziedzic M. Environmental risk assessment of antibiotics: an intensive care unit analysis. Chemosphere 2009, 77:962-967.
6. EC Technical guidance on risk assessment, TGD Part II. Technical Report, Institute for health and consumer Protection 2003, European Chemicals Bureau, European Commission (EC).
7. Emmanuel E., Perrodin Y., Keck G., Blanchard J.-M., Vermande P. Ecotoxicological risk assessment of hospital wastewater: a proposal of framework of raw effluent discharging in urban sewer network. J Hazard Mater 2005, A117:1-11.
8. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., McArdell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res 2011, 45:75-92.
9. Fatta-Kassinos D., Meric S., Nikolaou A. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research. Anal Bioanal Chem 2011, 399:251-275.
10. Ferrari B., Paxéus N., Lo Giudice R., Pollio A., Garrii J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid and diclofenac. Ecotoxicol Environ Saf 2003, 55:359-370.
11. Golet E., Alder A., Giger W. Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt valley watershed, Switzerland. Environ Sci Technol 2002, 36(17):3645-3651.
12. Gomez M.J., Petrovic M., Alba A.R.F., Barceló D. Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital effluent wastewaters. J Chromatogr 2006, A1114:224-233.
13. Gros M., Petrovicd́ M., Barceló D. Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 2006, 70:678-690.
14. Gros M., Petrovic M., Barceló D. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal Chem 2009, 81:898-912.
15. Hawkshead J.J. Hospital wastewater containing pharmaceutically active compounds and drug-resistant organisms: a source of environmental toxicity and increased antibiotic resistance. J Residuals Sci Technol 2008, 5:51-60.
16. Heberer T., Feldmann D. Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents-modeling versus measurements. J Hazard Mater 2005, 122:211-218.
17. Hernando M.D., Mezcua M., Fernandez-Alba A.R., Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69:334-342.
18. Jelicic I., Ahel M. Occurrence of phenazone analgesics and caffeine in Croatian municipal wastewaters. Fresenius Environ Bull 2003, 12(1):46-50.
19. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res 2009, 43:363-380.
20. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.R., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002, 36:1202-1211.
21. Kosma C.I., Lambropoulou D.A., Albanis T.A. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. J Hazard Mater 2010, 179:804-817.
22. Kostich M.S., Lazorchak J.M. Risk to aquatic organisms posed by human pharmaceutical use. Sci Total Environ 2008, 389:329-339.
23. Kummerer K. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospital in relation to other sources-a review. Chemosphere 2001, 45:957-969.
24. Langford K.H., Thomas K.V. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. Environ Int 2009, 35:766-770.
25. Lishman L., Smyth S.A., Sarafin K., Kleywegt S., Toito J., Peart T., et al. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci Total Environ 2006, 367:544-558.
26. Mahnik S., Lenz K., Weissenbacher N., Mader R., Fuerhacker M. Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bioreactor system. Chemosphere 2007, 6:30-37.
27. Ort C., Lawrence M., Reungoat J., Eagleham G., Carter S., Keller J. Determination of the fraction of pharmaceutical residues in wastewater originating from a hospital. Water Res 2010, 44:605-615.
28. Pal A., Gin K.Y.-H., Lin A.Y.-C., Reinhard M. Impacts of emerging contaminants on freshwater resources: review of recent occurrences, sources, fates and effects. Sci Total Environ 2010, 408:6062-6069.
29. Radjenovic J., Petrovic M., Barcelo D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 2009, 43:831-841.
30. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Total Environ 2006, 356:143-153.
31. Rosal R., Rodriguez A., Perdigon-Melon J.A., Petre A., Gracia- Calvo E., Gomez M.J., et al. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res 2010, 44:578-588.
32. Santos J.L., Aparicio I., Alonso E. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ Int 2007, 33:596-601.
33. Sim W.J., Lee J.W., Lee E.S., Shin S.K., Hwang S.R., Oh J.E. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospital and pharmaceutical manufactures. Chemosphere 2011, 82:179-186.
34. Sipma J., Osuna B., Collado N., Monclus H., Ferrero G., Comas J., et al. Comparison of removal of pharmaceuticals in MBR and activated sludge systems. Desalination 2010, 250:653-659.
35. Suarez S., Lema J., Omil F. Pre-treatment of hospital wastewater by coagulation-flocculation and flotation. Bioresour Technol 2009, 100:2138-2146.
36. Sui Q., Huang J., Deng S., Yu G., Fan Q. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Res 2010, 44:417-426.
37. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 2005, 39:1761-1772.
38. Terzic S., Senta I., Ahel M., Gros M., Petrovic M., Barcelò D., et al. Occurrence and fate of emerging contaminants in Western Balkan Region. Sci Total Environ 2009, 399:66-77.
39. Thomas K.V., Dye C., Schlabach M., Langford K.H. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works. J Environ Monit 2007, 9:1410-1418.
40. Verlicchi P., Galletti A., Petrovic M., Barcelò D. Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. J Hydrol 2010, 389:416-428.
41. Verlicchi P, Galletti A, Al Aukidy M. Hospital Wastewaters: Quali-quantitative Characterization and Strategies for Their Treatment and Disposal, Springer. In: SK Sharma and R Sanghi, editors. Wastewater reuse and management. UK: Springer; accepted for publication, in press.
42. Zhao J.L., Ying G.G., Liu Y.S., Chen F., Yang J.F., Wang L., et al. Occurrence and screening level risk assessment of human pharmaceutical in the Pearl River system, South China. Environ Toxicol Chem 2010, 29:1377-1384.